Lorena Pérez-Fajardo

Novel Treatments for Age-Related Macular Degeneration: A Review of Clinical Advances in Sustained Drug Delivery Systems

Y. Jiménez-Gómez, David Alba-Molina, F. Reyes-Ortega, 2022, Pharmaceutics.

A study protocol for a multicentre randomised clinical trial evaluating the safety and feasibility of a bioengineered human allogeneic nanostructured anterior cornea in patients with advanced corneal trophic ulcers refractory to conventional treatment

S. Arias-Santiago, M. Alaminos, A. Campos, 2017, BMJ Open.

Treatment of neovascular age-related macular degeneration within 48 h from diagnosis improves long-term functional outcome.

Y. Jiménez-Gómez, M. Gonzalez-Andrades, C. González-Gallardo, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.